Factors Impacting the Overall Survival of Patients Irradiated for Invasive Carcinoma of the Urinary Bladder

In Vivo. 2017 Jul-Aug;31(4):741-744. doi: 10.21873/invivo.11124.

Abstract

Background/aim: To contribute to personalisation of treatment for patients with carcinoma of the urinary bladder, 11 factors were analyzed for survival.

Patients and methods: Data from 61 patients receiving definitive irradiation for carcinoma of the urinary bladder were retrospectively evaluated, namely gender, age, T-stage, N-stage, grading, pack years, smoking during irradiation, upfront transurethral resection of the bladder tumour (TURBT), equivalent dose in 2-Gy fractions (EQD2), chemotherapy and Karnofsky performance score (KPS).

Results: On univariate analysis, female gender (p=0.007), <40 pack years (p=0.029), not smoking during irradiation (p=0.037), TURBT (p=0.007) and KPS >70 (p<0.001) led to improved survival; EQD2 >55 Gy showed a trend (p=0.065) for such association. On Cox regression, gender [risk ratio (RR)=2.81; p=0.039], TURBT (RR=4.44; p=0.033) and KPS (RR=3.45; p=0.018) remained significant.

Conclusion: This study identified independent predictors of survival in patients irradiated for carcinoma of the urinary bladder and contributes to creation of personalised treatment programs.

Keywords: Carcinoma of the urinary bladder; definitive treatment; independent predictive factors; irradiation; overall survival.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Carcinoma / epidemiology*
  • Carcinoma / pathology
  • Carcinoma / radiotherapy*
  • Disease-Free Survival
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Karnofsky Performance Status
  • Male
  • Middle Aged
  • Neoplasm Invasiveness / pathology
  • Neoplasm Staging
  • Time Factors
  • Treatment Outcome
  • Urinary Bladder / pathology
  • Urinary Bladder / radiation effects
  • Urinary Bladder Neoplasms / epidemiology*
  • Urinary Bladder Neoplasms / pathology
  • Urinary Bladder Neoplasms / radiotherapy*